Literature DB >> 19330466

Methylentetrahydrofolate reductase and nitric oxide synthase polymorphism in patients with atherosclerosis and diabetes.

Gábor Viktor Szabó1, Alíz Kunstár, György Acsády.   

Abstract

The development of the atherosclerosis is based on multifactorial causes. In addition to the traditional risk factors, gene polymorphisms can play a role in the disease. Therefore in this study we investigated whether the eNOS and MTHFR gene polymorphisms is associated with myocardial infarction and stroke in patients with or without diabetes. We have identified polymorphisms in the NOS 3 gene and one of these polymorphisms, Glu(298-->)Asp, was found to be a major risk factor for carotid artery disease and myocardial infarction. Our results indicate that the MTHFR G677T allele is significantly associated with MI. MTHFR 677 G/T genotyping may be of clinical importance as a prognostic and therapeutic marker, although further studies are needed to substantiate this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19330466     DOI: 10.1007/s12253-009-9163-z

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  23 in total

1.  The A677V MTHFR allele is not associated with carotid atherosclerosis in octogenarians.

Authors:  G Zuliani; S Volpato; P Mecocci; A Cherubini
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

2.  Early carotid atherosclerosis and family history of vascular disease: specific effects on arterial sites have implications for genetic studies.

Authors:  Paula Jerrard-Dunne; Hugh S Markus; Donata A Steckel; Alexandra Buehler; Stefan von Kegler; Matthias Sitzer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

3.  Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms.

Authors:  Aline S Marroni; Ingrid F Metzger; Debora C Souza-Costa; Sabrina Nagassaki; Valeria C Sandrim; Ronan X Correa; Fabricio Rios-Santos; Jose E Tanus-Santos
Journal:  Nitric Oxide       Date:  2005-05       Impact factor: 4.427

4.  Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease.

Authors:  N Jeerooburkhan; L C Jones; S Bujac; J A Cooper; G J Miller; P Vallance; S E Humphries; A D Hingorani
Journal:  Hypertension       Date:  2001-11       Impact factor: 10.190

5.  Lack of association between carotid intima-media thickness and methylenetetrahydrofolate reductase gene polymorphism or serum homocysteine in non-insulin-dependent diabetes mellitus.

Authors:  A Mazza; C Motti; A Nulli; G Marra; A Gnasso; A Pastore; G Federici; C Cortese
Journal:  Metabolism       Date:  2000-06       Impact factor: 8.694

6.  Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants.

Authors:  J E Tanus-Santos; M Desai; D A Flockhart
Journal:  Pharmacogenetics       Date:  2001-11

7.  Association between the NOS3 (-786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease.

Authors:  R Alvarez; P González; A Batalla; J R Reguero; G Iglesias-Cubero; S Hevia; A Cortina; E Merino; I González; V Alvarez; E Coto
Journal:  Nitric Oxide       Date:  2001-08       Impact factor: 4.427

Review 8.  The controversy over homocysteine and cardiovascular risk.

Authors:  P M Ueland; H Refsum; S A Beresford; S E Vollset
Journal:  Am J Clin Nutr       Date:  2000-08       Impact factor: 7.045

9.  The A677V methylenetetrahydrofolate reductase gene polymorphism and carotid atherosclerosis.

Authors:  I Bova; J Chapman; C Sylantiev; A D Korczyn; N M Bornstein
Journal:  Stroke       Date:  1999-10       Impact factor: 7.914

10.  The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study.

Authors:  Gian Paolo Rossi; Maurizio Cesari; Mario Zanchetta; Stefania Colonna; Giuseppe Maiolino; Luigi Pedon; Martina Cavallin; Pietro Maiolino; Achille C Pessina
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094

View more
  7 in total

Review 1.  The genetics of vascular complications in diabetes mellitus.

Authors:  Dan Farbstein; Andrew P Levy
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

2.  Tumornecrosis-factor-α 308 GA polymorphism in atherosclerotic patients.

Authors:  Gábor Viktor Szabó; György Acsády
Journal:  Pathol Oncol Res       Date:  2011-04-01       Impact factor: 3.201

3.  Evaluation of Association Studies and Meta-Analyses of eNOS Polymorphisms in Type 2 Diabetes Mellitus Risk.

Authors:  Di Wang; Liangshu Liu; Chengyu Zhang; Wensheng Lu; Feifei Wu; Xiaofeng He
Journal:  Front Genet       Date:  2022-06-27       Impact factor: 4.772

4.  The role and importance of gene polymorphisms in the development of atherosclerosis.

Authors:  Gábor Viktor Szabó
Journal:  Interv Med Appl Sci       Date:  2013-03-19

5.  Association between NOS3 G894T, T-786C and 4a/4b Variants and Coronary Artery Diseases in Iranian Population.

Authors:  Hamid Reza Joshaghani; Aref Salehi; Esmaeal Samadian; Roghayeh Gharaei; Ali Reza Ahmadi
Journal:  Iran J Public Health       Date:  2018-12       Impact factor: 1.429

6.  Association analysis of genetic variations of eNOS and α2β1 integrin genes with type 2 diabetic retinopathy.

Authors:  Rania Azmy; Ashraf Dawood; Ayman Kilany; Yasser El-Ghobashy; Amin Faisal Ellakwa; May El-Daly
Journal:  Appl Clin Genet       Date:  2012-07-24

7.  Endothelial nitric oxide synthase gene G894T polymorphism and myocardial infarction: a meta-analysis of 34 studies involving 21,068 subjects.

Authors:  Jian-Quan Luo; Jia-Gen Wen; Hong-Hao Zhou; Xiao-Ping Chen; Wei Zhang
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.